Global Breathalyzer and Drug Testing Equipment Market - 2023-2030

Market Overview

Breathalyzer And Drug Testing Equipment Market size was valued at US$ YY million in 2022 and is estimated to reach US$ YY million by 2030, growing at a CAGR of 16.8% during the forecast period (2023-2030).

Alcohol screening devices perform pretests in police, industrial and personal applications fast, reliable and hygienically. The breathalyzers also provide data storage for quick access to past test results. A breathalyzer test uses a diagnostic device to estimate a person's blood alcohol content (BAC). By blowing into the device, a person can determine whether they are over the legal limit to drive. Measuring the amount of alcohol, or ethanol, in a person's system requires a blood, saliva, urine, or breath sample.

Market Dynamics

Technological advancements drive the global breathalyzer and drug testing equipment market. The growing adoption of breathalyzers and drug testing equipment, the increasing number of drunk and drive cases and drug addiction and stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol boosts the market.

Rising driving incidences under the influence of drugs and alcohol drives market growth

The stringent government regulations and laws to reduce driving incidences under the influence of drugs and alcohol drive the market in the forecast period. As per the World Health Organization Report 2022, road traffic injuries are a major public health problem and a foremost cause of death and injury worldwide. Every year around 1.3 million people die, and millions more are injured or disabled due to road crashes, mostly in low- and middle-income countries. As well as creating enormous social costs for individuals, families and communities, road traffic injuries heavily burden health services and economies.

Alcohol plays a cultural and social role in many societies. However, the harmful effects of alcohol experienced in many aspects of daily life are undeniable. An extensive body of literature identifies that driving after drinking alcohol significantly raises the risk of a crash and the severity of that crash, resulting in deaths and serious injuries.

In its latest reports, the WHO estimates that between 5% and 35% of global road deaths are alcohol-related. In most high-income countries, about 20% of fatally injured drivers have blood alcohol concentration levels above the legal limit. Studies in low- and middle-income countries have shown that 33% and 69% of fatally injured drivers and 8% and 29% of non-fatally injured drivers had consumed alcohol before their crashes. The rising incidences under the influence of drugs and alcohol and rising government regulations drive the market worldwide.

The inaccurate and wrong results provided by some breathalyzers will hamper the growth of the market

However, inaccurate and wrong results are provided by some breathalyzers due to improper calibration, incorrect chemical solutions, inappropriate modifications, faulty programming, improper methodology, electronic interference, certain health conditions, and exposure to chemicals. These factors are hampering the market growth.

COVID-19 Impact Analysis

The appearance of COVID-19 positively impacted the global breathalyzer and drug testing equipment market. According to the article published in Disaster Medicine and Public Health Preparedness in 2021, due to the coronavirus disease 2019 pandemic, there is a demand for accurate, rapid, and easy-to-administer diagnostic tools to support communities address local outbreaks and assess the spread of disease. Artificial intelligence within breath analysis techniques has been shown to potentially diagnose various diseases, such as cancer and lung disease, by analyzing volatile organic compounds in exhaled breath. This, combined with their rapid, easy-to-use, and noninvasive nature, makes them a suitable candidate for use in diagnosing COVID-19 in large-scale public health operations.

In April 2022, the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test that detects chemical compounds in breath samples related to a SARS-CoV-2 infection. The test can be conducted in environments where the patient specimen is collected and examined, such as doctor's offices, hospitals and mobile testing sites, utilizing an instrument about the carry-on luggage size.

The InspectIR COVID-19 Breathalyzer employs gas chromatography gas mass-spectrometry (GC-MS) to isolate and identify chemical mixtures and quickly detect five Volatile Organic Compounds (VOC) associated with SARS-CoV-2 infection in an exhaled breath when the InspectIR COVID-19 Breathalyzer detects VOC markers of SARS-CoV-2, a hypothetical (unconfirmed) positive test result is produced and should be confirmed with a molecular test.

Segment Analysis

The alcohol detection segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The alcohol detection segment accounts for the largest market share. Imagine the loss of lives caused due to people driving under the influence of alcohol. Through our alcohol detection device, police officers can instantly figure out people driving under the influence of alcohol and stop them, reducing drunk driving scenarios.

Manufacturers are providing the products in the market. For instance, Lifeloc Technologies, Inc. is a trusted U.S. manufacturer of precise, reliable And easy-to-use portable breath alcohol testing instruments (breathalyzers). Lifeloc's L Series of portable breath alcohol testers or "breathalyzers" are state-of-the-art and the most powerful, simple to use and advanced product on the market.

Also, in October 2022, Cannabix Technologies Inc., developer of breath testing devices for law enforcement and the workplace, reported that the Company had created a cutting-edge Contactless Alcohol Breathalyzer for workplaces and vehicles. Cannabix engineers have developed a suite of Contactless Alcohol Breathalyzer (CAB) offerings, including wall-mounted and in-vehicle (behind the steering column) versions.

Geographical Analysis

North America region holds the largest market share of the global Breathalyzer and Drug Testing Equipment market

North America dominates the breathalyzer and drug testing equipment market and is anticipated to show a parallel trend over the forecast period. An increasing number of accidents and awareness programs in the North American region drive the market.

According to the WHO report 2022, consuming alcohol can be an enjoyable activity for some people. However, many people may not realize the impact on body and can impair the ability to perform routine tasks. Drinking and driving is a dangerous combination. Evidence notes that in the U.S., it is responsible for roughly 28 deaths a day, costing the U.S. approximately $44 billion annually.

In the U.S., half a million people are injured and 17,000 killed every year in drunk driving-related traffic crashes. Almost 40% of all youth road fatalities are directly related to alcohol consumption.

Using breathalyzers can help reduce the number of motor vehicle accidents involving an alcohol-impaired driver. This device estimates the concentration of alcohol in the breath to decide whether a person has drunk too much alcohol to drive safely. All these factors are driving the market in the North American region.

Competitive Landscape

The breathalyzer and drug testing equipment market are a moderately competitive presence of local and global companies. Some of the key players contributing to the market's growth are C4 Development, Cannabix Technologies Inc., Intoxalock, Hound Labs, BACtrack, Lion Laboratories Limited, Intoximeters, Inc., Lifeloc Technologies, Inc., Lifesafer, and Ekips Technologies, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to the growth of the breathalyzer and drug testing equipment market globally.

For instance,

In October 2022, Cannabix Technologies Inc., developer of marijuana breathalyzer devices for law enforcement and the workplace, reports it will be partaking in a mid-October study date to test a supplemental version of its FAIMS technology for the detection of Delta 9-tetrahydrocannabinol and related analytes in human breath in a complete multi-analysis study of subjects under the effect of marijuana in the southern United States.

C4 Development

Overview:

C4 Development provides the most advanced tailor-made alcohol tester and ITS products to different countries. Alcovisor, a series of alcohol breath analyzers created and manufactured by the company. Alcovisor provides drivers with a testing machine to measure their alcohol degree before driving.

Product Portfolio:

JupiterX: This is android 5.1, built-in printer, GPS, 4G/WIFI Photo Capture, provide evidential records by auto-capturing while subject blowing, 100,000 test data stored in memory, 4.3" color touch screen. The mouthpiece can be automatically ejected, and a USB PC connection.

The global breathalyzer and drug testing equipment market report would provide access to approximately 55+ market data tables, 55+ figures, and in the range of 200 (approximate) pages.